SCHEMBL4433013

SCHEMBL4433013

CCC(C[C@H](C)N)c1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 1/20 0.52
▸ SLC6A3 Q01959 2/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ GABBR2 O75899 6/20 0.40
▸ GABBR1 Q9UBS5 6/20 0.40
▸ LMNA P02545 3/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ THRB P10828 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8239806 0.81 ADRB2 (0.48) ADRB2GABBR2GABBR1LMNACYP2C9
SCHEMBL13784991 0.81 ADRA2A (0.38) CYP1A2CYP2D6TSHRPMP22ADRA2A
SCHEMBL3621043 0.80 ADRB2 (0.42) ADRB2GABBR2GABBR1LMNACYP2C9
SCHEMBL3621046 0.80 ADRB2 (0.42) ADRB2GABBR2GABBR1LMNACYP2C9
SCHEMBL18102233 0.79 ADRB2 (0.41) ADRB2GABBR2GABBR1LMNACYP2C9
SCHEMBL6278627 0.78 GABBR2 (0.56) ADRB2SLC6A3GABBR2GABBR1LMNA
SCHEMBL19803301 0.78 GABBR2 (0.56) ADRB2SLC6A3GABBR2GABBR1LMNA
SCHEMBL19803214 0.78 GABBR2 (0.56) ADRB2SLC6A3GABBR2GABBR1LMNA
SCHEMBL27644590 0.78 GABBR2 (0.49) GABBR2GABBR1LMNACYP2C9CYP1A2
SCHEMBL11493799 0.77 CYP17A1 (0.40) GABBR2GABBR1ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114906-A1 NOVEL 2-AMINOOXAZOLINES AS TAAR1 LIGANDS FOR CNS DISORDERS F. Hoffmann-Roche AG (CH) 2009-11-11 — — EP disclosed
WO-2008092785-A1 NOVEL 2-AMINOOXAZOLINES AS TAAR1 LIGANDS FOR CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-07 — — WO disclosed
Send feedback